US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SCYNEXIS Inc

0.7590

+0.06869.94%

Post-market: 0.75900.00000.00%18:10 EST

Volume:213.19K

Turnover:159.59K

Market Cap:31.85M

PE:-1.48

High:0.7800

Open:0.7104

Low:0.7003

Close:0.6904

52wk High:1.31

52wk Low:0.5650

Shares:41.97M

Float Shares:37.57M

Volume Ratio:0.57

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5129

EPS(LYR):-0.4388

ROE:-53.29%

ROA:-28.85%

PB:0.87

PE(LYR):-1.73

Loading ...

Overview Company News Filings

SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247

Scynexis Inc - to Initiate Phase 1 and 2 Studies of Scy-247 in 2026

THOMSON REUTERS

Scynexis Inc - Qidp Designation Ensures 10 Years Market Exclusivity for Scy-247

THOMSON REUTERS

SCYNEXIS Granted Nasdaq Extension to Regain Minimum Bid Price Compliance

Scynexis Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Requirement

THOMSON REUTERS

Scynexis Transfers Brexafemme New Drug Application to GSK

MT Newswires Live

Scynexis Inc - to Receive up to $145.5 Mln in Annual Net Sales Milestones as Well as Royalties

THOMSON REUTERS

Scynexis Completes Transfer of Brexafemme® New Drug Application to GSK

THOMSON REUTERS

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK

Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration

SCYNEXIS and Partners Secure $7 Million Annual NIH Grant for Novel Antifungal Development

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections

SCYNEXIS Inc reports results for the quarter ended September 30 - Earnings Summary

Antifungal drug developer Scynexis's Q3 net loss widens

BRIEF-Scynexis Q3 Pretax Profit USD -8.591 Million

Scynexis Q3 Basic EPS USD -0.17

THOMSON REUTERS

SCYNEXIS Inc expected to post a loss of 20 cents a share - Earnings Preview

Scynexis Is Maintained at Buy by Guggenheim

Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCYX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SCYX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCYX\",,,,,undefined,":{"symbol":"SCYX","market":"US","secType":"STK","nameCN":"SCYNEXIS Inc","latestPrice":0.759,"timestamp":1770411600000,"preClose":0.6904,"halted":0,"volume":213194,"hourTrading":{"tag":"盘后","latestPrice":0.759,"preClose":0.759,"latestTime":"18:10 EST","volume":37,"amount":28.1281,"timestamp":1770419411969,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.09936268829663962,"floatShares":37569200,"shares":41965058,"eps":-0.512889,"marketStatus":"Market Closed","change":0.0686,"latestTime":"02-06 16:00:00 EST","open":0.7104,"high":0.78,"low":0.70025,"amount":159592.5726454,"amplitude":0.115513,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.512889,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1399003200000,"exchange":"NASDAQ","adjPreClose":0.6904,"preHourTrading":{"tag":"盘前","latestPrice":0.7105,"preClose":0.6904,"latestTime":"08:33 EST","volume":1691,"amount":1165.5682525,"timestamp":1770384827491,"change":0.0201,"changeRate":0.029114,"amplitude":0.077057},"postHourTrading":{"tag":"盘后","latestPrice":0.759,"preClose":0.759,"latestTime":"18:10 EST","volume":37,"amount":28.1281,"timestamp":1770419411969,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5667260795785074,"impliedVol":3.0502,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCYX\",,,,,undefined,":{"symbol":"SCYX","floatShares":37569200,"roa":"-28.85%","roe":"-53.29%","lyrEps":-0.438809,"volumeRatio":0.5667260795785074,"shares":41965058,"dividePrice":0,"high":0.78,"amplitude":0.115513,"preClose":0.6904,"low":0.70025,"week52Low":0.565,"pbRate":"0.87","psRate":"10.86","week52High":1.31,"institutionHeld":0,"latestPrice":0.759,"eps":-0.512889,"divideRate":0,"volume":213194,"delay":0,"ttmEps":-0.512889,"open":0.7104,"prevYearClose":0.6324,"prevWeekClose":0.711,"prevMonthClose":0.711,"prevQuarterClose":0.6324,"fiveDayClose":0.711,"twentyDayClose":0.6656,"sixtyDayClose":0.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCYX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-05","symbol":"SCYX","fiscalQuarterEnding":"2025/09","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-08-13","symbol":"SCYX","fiscalQuarterEnding":"2025/06","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-05-15","symbol":"SCYX","fiscalQuarterEnding":"2025/03","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-03-12","symbol":"SCYX","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2024-11-06","symbol":"SCYX","fiscalQuarterEnding":"2024/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCYX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCYX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1715144400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCYX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCYX","date":"2026-02-06","current":-1.479852,"percent":0.602116,"low":-6.893938,"twenty":-2.740507,"median":-1.497218,"eighty":-0.651264,"high":3.053916,"avg":-1.415696,"sd":1.650698,"marketCap":28972676},"quantilePoints":[{"date":"2021-02-12","current":-6.357027,"twenty":-3.118515,"median":-2.217378,"eighty":-1.65067,"marketCap":171207456},{"date":"2021-02-19","current":-6.306915,"twenty":-3.130813,"median":-2.217378,"eighty":-1.65067,"marketCap":169857848},{"date":"2021-02-26","current":-5.569558,"twenty":-3.163097,"median":-2.217378,"eighty":-1.65067,"marketCap":149999325},{"date":"2021-03-05","current":-5.820116,"twenty":-3.175433,"median":-2.216835,"eighty":-1.65067,"marketCap":156747367},{"date":"2021-03-12","current":-6.113628,"twenty":-3.180954,"median":-2.216835,"eighty":-1.65067,"marketCap":164652216},{"date":"2021-03-19","current":-5.984769,"twenty":-3.195635,"median":-2.216835,"eighty":-1.65067,"marketCap":161181794},{"date":"2021-03-26","current":-5.476493,"twenty":-3.218458,"median":-2.217378,"eighty":-1.65067,"marketCap":147492910},{"date":"2021-04-01","current":-3.094258,"twenty":-3.218458,"median":-2.217378,"eighty":-1.65067,"marketCap":170756601},{"date":"2021-04-09","current":-3.150313,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":173850018},{"date":"2021-04-16","current":-2.888721,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":159414073},{"date":"2021-04-23","current":-2.735503,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":150958734},{"date":"2021-04-30","current":-2.826284,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":155968470},{"date":"2021-05-07","current":-2.568329,"twenty":-3.221771,"median":-2.216835,"eighty":-1.65067,"marketCap":141733252},{"date":"2021-05-14","current":-2.658053,"twenty":-3.195635,"median":-2.216835,"eighty":-1.65067,"marketCap":146684632},{"date":"2021-05-21","current":-3.360464,"twenty":-3.189491,"median":-2.216835,"eighty":-1.65067,"marketCap":177630757},{"date":"2021-05-28","current":-3.739053,"twenty":-3.189491,"median":-2.216835,"eighty":-1.65067,"marketCap":197642585},{"date":"2021-06-04","current":-3.137994,"twenty":-3.184089,"median":-2.216835,"eighty":-1.65067,"marketCap":165871230},{"date":"2021-06-11","current":-3.169218,"twenty":-3.180386,"median":-2.216835,"eighty":-1.65067,"marketCap":167521690},{"date":"2021-06-18","current":-2.927233,"twenty":-3.175433,"median":-2.216835,"eighty":-1.65067,"marketCap":154730625},{"date":"2021-06-25","current":-3.102867,"twenty":-3.170462,"median":-2.216835,"eighty":-1.65067,"marketCap":164014462},{"date":"2021-07-02","current":-3.079449,"twenty":-3.161457,"median":-2.216835,"eighty":-1.65067,"marketCap":162776617},{"date":"2021-07-09","current":-2.849174,"twenty":-3.150313,"median":-2.216835,"eighty":-1.65067,"marketCap":150604475},{"date":"2021-07-16","current":-2.618898,"twenty":-3.126691,"median":-2.216835,"eighty":-1.65067,"marketCap":138432332},{"date":"2021-07-23","current":-2.755502,"twenty":-3.118515,"median":-2.216835,"eighty":-1.65067,"marketCap":145653095},{"date":"2021-07-30","current":-2.720375,"twenty":-3.109416,"median":-2.216835,"eighty":-1.65067,"marketCap":143796327},{"date":"2021-08-06","current":-2.700861,"twenty":-3.100946,"median":-2.216835,"eighty":-1.65067,"marketCap":142764790},{"date":"2021-08-13","current":-2.443264,"twenty":-3.100946,"median":-2.223071,"eighty":-1.65067,"marketCap":129148495},{"date":"2021-08-20","current":-3.04081,"twenty":-3.105002,"median":-2.224141,"eighty":-1.65067,"marketCap":136289125},{"date":"2021-08-27","current":-3.315364,"twenty":-3.116329,"median":-2.224141,"eighty":-1.65067,"marketCap":148594617},{"date":"2021-09-03","current":-3.44487,"twenty":-3.125006,"median":-2.224141,"eighty":-1.65067,"marketCap":154399094},{"date":"2021-09-10","current":-3.496673,"twenty":-3.126691,"median":-2.224141,"eighty":-1.65067,"marketCap":156720885},{"date":"2021-09-17","current":-3.144416,"twenty":-3.126691,"median":-2.224141,"eighty":-1.65067,"marketCap":140932707},{"date":"2021-09-24","current":-2.890583,"twenty":-3.118515,"median":-2.224141,"eighty":-1.65067,"marketCap":129555932},{"date":"2021-10-01","current":-2.678193,"twenty":-3.109416,"median":-2.224141,"eighty":-1.65067,"marketCap":120036589},{"date":"2021-10-08","current":-2.662652,"twenty":-3.097415,"median":-2.224141,"eighty":-1.65067,"marketCap":119340052},{"date":"2021-10-15","current":-2.885403,"twenty":-3.086891,"median":-2.224141,"eighty":-1.65067,"marketCap":129323753},{"date":"2021-10-22","current":-2.683373,"twenty":-3.078621,"median":-2.224141,"eighty":-1.65067,"marketCap":120268768},{"date":"2021-10-29","current":-2.595308,"twenty":-3.0724,"median":-2.224141,"eighty":-1.65067,"marketCap":116321724},{"date":"2021-11-05","current":-2.916484,"twenty":-3.060574,"median":-2.224141,"eighty":-1.65067,"marketCap":130716827},{"date":"2021-11-12","current":-2.791269,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":129330653},{"date":"2021-11-19","current":-3.685509,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":170764362},{"date":"2021-11-26","current":-3.840579,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":177949399},{"date":"2021-12-03","current":-3.463068,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":160457771},{"date":"2021-12-10","current":-3.881024,"twenty":-3.05662,"median":-2.224141,"eighty":-1.65067,"marketCap":179823365},{"date":"2021-12-17","current":-3.832172,"twenty":-3.069246,"median":-2.224141,"eighty":-1.65067,"marketCap":177559854},{"date":"2021-12-23","current":-4.15485,"twenty":-3.077756,"median":-2.224141,"eighty":-1.65067,"marketCap":192510816},{"date":"2021-12-31","current":-3.754753,"twenty":-3.08102,"median":-2.224141,"eighty":-1.65067,"marketCap":173972738},{"date":"2022-01-07","current":-3.896326,"twenty":-3.094419,"median":-2.225543,"eighty":-1.65067,"marketCap":180532365},{"date":"2022-01-14","current":-3.723977,"twenty":-3.109903,"median":-2.225543,"eighty":-1.65067,"marketCap":172546732},{"date":"2022-01-21","current":-3.04689,"twenty":-3.113285,"median":-2.225543,"eighty":-1.65067,"marketCap":141174598},{"date":"2022-01-28","current":-2.837609,"twenty":-3.113285,"median":-2.225543,"eighty":-1.65067,"marketCap":131477757},{"date":"2022-02-04","current":-2.831453,"twenty":-3.11599,"median":-2.225543,"eighty":-1.65067,"marketCap":131192556},{"date":"2022-02-11","current":-2.960715,"twenty":-3.122736,"median":-2.225543,"eighty":-1.65067,"marketCap":137181782},{"date":"2022-02-18","current":-2.720657,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":126058934},{"date":"2022-02-25","current":-2.591395,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":120069709},{"date":"2022-03-04","current":-2.382114,"twenty":-3.118352,"median":-2.225543,"eighty":-1.65067,"marketCap":110372868},{"date":"2022-03-11","current":-2.443667,"twenty":-3.118352,"median":-2.230097,"eighty":-1.65067,"marketCap":113224880},{"date":"2022-03-18","current":-3.108443,"twenty":-3.118352,"median":-2.230097,"eighty":-1.65067,"marketCap":144026611},{"date":"2022-03-25","current":-2.966871,"twenty":-3.118352,"median":-2.240172,"eighty":-1.65067,"marketCap":137466983},{"date":"2022-04-01","current":-3.408068,"twenty":-3.128627,"median":-2.246144,"eighty":-1.65067,"marketCap":112009557},{"date":"2022-04-08","current":-3.161489,"twenty":-3.150313,"median":-2.257272,"eighty":-1.65067,"marketCap":103905506},{"date":"2022-04-14","current":-2.950136,"twenty":-3.150313,"median":-2.27274,"eighty":-1.65067,"marketCap":96959177},{"date":"2022-04-22","current":-2.288199,"twenty":-3.150313,"median":-2.282474,"eighty":-1.65067,"marketCap":75203944},{"date":"2022-04-29","current":-2.622099,"twenty":-3.150313,"median":-2.290881,"eighty":-1.65067,"marketCap":86177910},{"date":"2022-05-06","current":-2.220473,"twenty":-3.150313,"median":-2.296896,"eighty":-1.65067,"marketCap":72978059},{"date":"2022-05-13","current":-2.004683,"twenty":-3.150313,"median":-2.296896,"eighty":-1.658123,"marketCap":67439546},{"date":"2022-05-20","current":-2.053105,"twenty":-3.150313,"median":-2.296896,"eighty":-1.667779,"marketCap":69068520},{"date":"2022-05-27","current":-1.994999,"twenty":-3.150313,"median":-2.296896,"eighty":-1.675332,"marketCap":67113751},{"date":"2022-06-03","current":-2.024052,"twenty":-3.150313,"median":-2.296896,"eighty":-1.679008,"marketCap":68091136},{"date":"2022-06-10","current":-1.88847,"twenty":-3.150313,"median":-2.296896,"eighty":-1.69591,"marketCap":63530007},{"date":"2022-06-17","current":-1.723834,"twenty":-3.150313,"median":-2.296896,"eighty":-1.715251,"marketCap":57991493},{"date":"2022-06-24","current":-1.994999,"twenty":-3.150313,"median":-2.298884,"eighty":-1.721944,"marketCap":67113751},{"date":"2022-07-01","current":-1.810994,"twenty":-3.150313,"median":-2.298884,"eighty":-1.72802,"marketCap":60923648},{"date":"2022-07-08","current":-1.907839,"twenty":-3.150313,"median":-2.298884,"eighty":-1.740985,"marketCap":64181597},{"date":"2022-07-15","current":-1.994999,"twenty":-3.150313,"median":-2.298884,"eighty":-1.751618,"marketCap":67113751},{"date":"2022-07-22","current":-2.120897,"twenty":-3.150313,"median":-2.298884,"eighty":-1.761561,"marketCap":71349085},{"date":"2022-07-29","current":-2.23711,"twenty":-3.150313,"median":-2.298884,"eighty":-1.775155,"marketCap":75258624},{"date":"2022-08-05","current":-2.769755,"twenty":-3.150313,"median":-2.307215,"eighty":-1.781941,"marketCap":93177344},{"date":"2022-08-12","current":-2.785692,"twenty":-3.150313,"median":-2.320867,"eighty":-1.800361,"marketCap":93713472},{"date":"2022-08-19","current":-1.839196,"twenty":-3.150313,"median":-2.320867,"eighty":-1.804979,"marketCap":89465871},{"date":"2022-08-26","current":-1.684811,"twenty":-3.150313,"median":-2.320867,"eighty":-1.8075,"marketCap":81955962},{"date":"2022-09-02","current":-1.637825,"twenty":-3.150313,"median":-2.320867,"eighty":-1.8075,"marketCap":79670338},{"date":"2022-09-09","current":-1.704949,"twenty":-3.150313,"median":-2.320867,"eighty":-1.805621,"marketCap":82935516},{"date":"2022-09-16","current":-1.953307,"twenty":-3.150313,"median":-2.320867,"eighty":-1.810687,"marketCap":95016673},{"date":"2022-09-23","current":-1.584125,"twenty":-3.150313,"median":-2.320867,"eighty":-1.805621,"marketCap":77058196},{"date":"2022-09-30","current":-1.610975,"twenty":-3.150313,"median":-2.320867,"eighty":-1.80131,"marketCap":78364267},{"date":"2022-10-07","current":-1.738511,"twenty":-3.150313,"median":-2.320867,"eighty":-1.783124,"marketCap":84568105},{"date":"2022-10-14","current":-1.845909,"twenty":-3.150313,"median":-2.320867,"eighty":-1.781941,"marketCap":89792389},{"date":"2022-10-21","current":-1.604263,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":78037749},{"date":"2022-10-28","current":-1.6244,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":79017302},{"date":"2022-11-04","current":-1.496864,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":72813464},{"date":"2022-11-11","current":-0.828804,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":64334274},{"date":"2022-11-18","current":-0.955018,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":74131371},{"date":"2022-11-25","current":-1.030746,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":80009630},{"date":"2022-12-02","current":-0.96764,"twenty":-3.150313,"median":-2.320867,"eighty":-1.795616,"marketCap":75111081},{"date":"2022-12-09","current":-0.891911,"twenty":-3.150313,"median":-2.320867,"eighty":-1.783124,"marketCap":69232823},{"date":"2022-12-16","current":-0.807769,"twenty":-3.150313,"median":-2.320867,"eighty":-1.772983,"marketCap":62701424},{"date":"2022-12-23","current":-0.656312,"twenty":-3.150313,"median":-2.320867,"eighty":-1.753201,"marketCap":50944907},{"date":"2022-12-30","current":-0.656312,"twenty":-3.150313,"median":-2.320867,"eighty":-1.74912,"marketCap":50944907},{"date":"2023-01-06","current":-0.694176,"twenty":-3.1448,"median":-2.315558,"eighty":-1.739044,"marketCap":53884036},{"date":"2023-01-13","current":-0.79094,"twenty":-3.1448,"median":-2.299164,"eighty":-1.737737,"marketCap":61395144},{"date":"2023-01-20","current":-0.706798,"twenty":-3.1448,"median":-2.293985,"eighty":-1.722893,"marketCap":54863746},{"date":"2023-01-27","current":-0.73204,"twenty":-3.1448,"median":-2.283629,"eighty":-1.715084,"marketCap":56823166},{"date":"2023-02-03","current":-0.706798,"twenty":-3.1448,"median":-2.273131,"eighty":-1.711661,"marketCap":54863746},{"date":"2023-02-10","current":-0.664726,"twenty":-3.1448,"median":-2.258737,"eighty":-1.698236,"marketCap":51598047},{"date":"2023-02-17","current":-0.643691,"twenty":-3.1448,"median":-2.24967,"eighty":-1.68771,"marketCap":49965197},{"date":"2023-02-24","current":-0.614241,"twenty":-3.1448,"median":-2.243009,"eighty":-1.678099,"marketCap":47679208},{"date":"2023-03-03","current":-0.740455,"twenty":-3.1448,"median":-2.240172,"eighty":-1.672419,"marketCap":57476305},{"date":"2023-03-10","current":-0.559548,"twenty":-3.130969,"median":-2.226946,"eighty":-1.660764,"marketCap":43433799},{"date":"2023-03-17","current":-0.48382,"twenty":-3.126285,"median":-2.217921,"eighty":-1.651249,"marketCap":37555540},{"date":"2023-03-24","current":-0.786733,"twenty":-3.126285,"median":-2.207748,"eighty":-1.641348,"marketCap":61068575},{"date":"2023-03-31","current":-1.591689,"twenty":-3.126285,"median":-2.205971,"eighty":-1.634541,"marketCap":99972393},{"date":"2023-04-06","current":-1.888804,"twenty":-3.126285,"median":-2.205717,"eighty":-1.631112,"marketCap":118633906},{"date":"2023-04-14","current":-1.607606,"twenty":-3.126285,"median":-2.18887,"eighty":-1.630145,"marketCap":100972116},{"date":"2023-04-21","current":-1.665968,"twenty":-3.126285,"median":-2.188551,"eighty":-1.630145,"marketCap":104637771},{"date":"2023-04-28","current":-1.623523,"twenty":-3.126285,"median":-2.178151,"eighty":-1.624324,"marketCap":101971840},{"date":"2023-05-05","current":-1.761656,"twenty":-3.126285,"median":-2.154669,"eighty":-1.624324,"marketCap":110647849},{"date":"2023-05-12","current":-1.100719,"twenty":-3.126285,"median":-2.151175,"eighty":-1.622994,"marketCap":100422965},{"date":"2023-05-19","current":-1.14875,"twenty":-3.125433,"median":-2.14185,"eighty":-1.612288,"marketCap":104805058},{"date":"2023-05-26","current":-1.062694,"twenty":-3.116667,"median":-2.137172,"eighty":-1.605294,"marketCap":96953808},{"date":"2023-06-02","current":-1.048685,"twenty":-3.099745,"median":-2.130957,"eighty":-1.602142,"marketCap":95675698},{"date":"2023-06-09","current":-1.036677,"twenty":-3.082073,"median":-2.130957,"eighty":-1.591689,"marketCap":94580174},{"date":"2023-06-16","current":-1.096716,"twenty":-3.06982,"median":-2.125104,"eighty":-1.582484,"marketCap":100057791},{"date":"2023-06-23","current":-1.116729,"twenty":-3.04689,"median":-2.111759,"eighty":-1.571504,"marketCap":101883663},{"date":"2023-06-30","current":-1.208789,"twenty":-3.030346,"median":-2.111759,"eighty":-1.570245,"marketCap":110282674},{"date":"2023-07-07","current":-1.14875,"twenty":-3.009132,"median":-2.111759,"eighty":-1.56344,"marketCap":104805058},{"date":"2023-07-14","current":-1.096716,"twenty":-2.994168,"median":-2.105564,"eighty":-1.552469,"marketCap":100057791},{"date":"2023-07-21","current":-1.188776,"twenty":-2.977539,"median":-2.097437,"eighty":-1.540618,"marketCap":108456802},{"date":"2023-07-28","current":-1.124734,"twenty":-2.966385,"median":-2.092561,"eighty":-1.529197,"marketCap":102614012},{"date":"2023-08-04","current":-1.152753,"twenty":-2.955233,"median":-2.086267,"eighty":-1.527736,"marketCap":105170232},{"date":"2023-08-11","current":-1.196781,"twenty":-2.955233,"median":-2.077442,"eighty":-1.516984,"marketCap":109187151},{"date":"2023-08-18","current":2.320808,"twenty":-2.955233,"median":-2.073364,"eighty":-1.508165,"marketCap":102976592},{"date":"2023-08-25","current":2.588916,"twenty":-2.955233,"median":-2.073364,"eighty":-1.501484,"marketCap":114872804},{"date":"2023-09-01","current":2.949186,"twenty":-2.955233,"median":-2.073364,"eighty":-1.496259,"marketCap":130858340},{"date":"2023-09-08","current":2.647565,"twenty":-2.955233,"median":-2.073364,"eighty":-1.484058,"marketCap":117475101},{"date":"2023-09-15","current":2.840267,"twenty":-2.955233,"median":-2.073364,"eighty":-1.480436,"marketCap":126025504},{"date":"2023-09-22","current":2.848646,"twenty":-2.955233,"median":-2.073364,"eighty":-1.457662,"marketCap":126397261},{"date":"2023-09-29","current":1.927025,"twenty":-2.955233,"median":-2.073364,"eighty":-1.435218,"marketCap":85504029},{"date":"2023-10-06","current":1.876755,"twenty":-2.955233,"median":-2.073364,"eighty":-1.400777,"marketCap":83273489},{"date":"2023-10-13","current":1.675674,"twenty":-2.955233,"median":-2.073364,"eighty":-1.384901,"marketCap":74351330},{"date":"2023-10-20","current":1.675674,"twenty":-2.955233,"median":-2.073364,"eighty":-1.356336,"marketCap":74351330},{"date":"2023-10-27","current":1.432701,"twenty":-2.957253,"median":-2.073364,"eighty":-1.340811,"marketCap":63570387},{"date":"2023-11-03","current":1.508107,"twenty":-2.957253,"median":-2.073364,"eighty":-1.330152,"marketCap":66916197},{"date":"2023-11-10","current":1.415944,"twenty":-2.957253,"median":-2.073364,"eighty":-1.317564,"marketCap":62826873},{"date":"2023-11-17","current":0.814265,"twenty":-2.957253,"median":-2.073364,"eighty":-1.294712,"marketCap":58788322},{"date":"2023-11-24","current":0.855494,"twenty":-2.957253,"median":-2.073364,"eighty":-1.244813,"marketCap":61764946},{"date":"2023-12-01","current":0.865801,"twenty":-2.957253,"median":-2.073364,"eighty":-1.207188,"marketCap":62509102},{"date":"2023-12-08","current":0.876108,"twenty":-2.95658,"median":-2.073364,"eighty":-1.196781,"marketCap":63253258},{"date":"2023-12-15","current":0.855494,"twenty":-2.95658,"median":-2.073364,"eighty":-1.190278,"marketCap":61764946},{"date":"2023-12-22","current":0.963719,"twenty":-2.95658,"median":-2.073364,"eighty":-1.190278,"marketCap":69578584},{"date":"2023-12-29","current":1.118326,"twenty":-2.957253,"median":-2.073364,"eighty":-1.193382,"marketCap":80740923},{"date":"2024-01-05","current":0.999794,"twenty":-2.957926,"median":-2.073364,"eighty":-1.188776,"marketCap":72183130},{"date":"2024-01-12","current":1.030716,"twenty":-2.957926,"median":-2.073364,"eighty":-1.172766,"marketCap":74415598},{"date":"2024-01-19","current":0.974026,"twenty":-2.958484,"median":-2.073364,"eighty":-1.166361,"marketCap":70322740},{"date":"2024-01-26","current":0.932798,"twenty":-2.957926,"median":-2.073364,"eighty":-1.14875,"marketCap":67346116},{"date":"2024-02-02","current":1.087405,"twenty":-2.957926,"median":-2.073364,"eighty":-1.13274,"marketCap":78508455},{"date":"2024-02-09","current":0.989487,"twenty":-2.957926,"median":-2.064896,"eighty":-1.124734,"marketCap":71438974},{"date":"2024-02-16","current":0.917337,"twenty":-2.952746,"median":-2.054166,"eighty":-1.116729,"marketCap":66229882},{"date":"2024-02-23","current":0.85034,"twenty":-2.947566,"median":-2.054166,"eighty":-1.108724,"marketCap":61392868},{"date":"2024-03-01","current":0.83488,"twenty":-2.945841,"median":-2.049856,"eighty":-1.101519,"marketCap":60276634},{"date":"2024-03-08","current":0.870955,"twenty":-2.945841,"median":-2.036863,"eighty":-1.092713,"marketCap":62881180},{"date":"2024-03-15","current":0.773037,"twenty":-2.938942,"median":-2.028894,"eighty":-1.064615,"marketCap":55811698},{"date":"2024-03-22","current":0.721501,"twenty":-2.924541,"median":-2.01577,"eighty":-1.038857,"marketCap":52090918},{"date":"2024-03-28","current":0.734385,"twenty":-2.913921,"median":-2.005766,"eighty":-1.030746,"marketCap":53021113},{"date":"2024-04-05","current":0.946076,"twenty":-2.893007,"median":-2.000764,"eighty":-0.99757,"marketCap":63425848},{"date":"2024-04-12","current":0.901024,"twenty":-2.885403,"median":-1.996572,"eighty":-0.955018,"marketCap":60405569},{"date":"2024-04-19","current":0.791212,"twenty":-2.874541,"median":-1.991971,"eighty":-0.891911,"marketCap":53043640},{"date":"2024-04-26","current":0.828393,"twenty":-2.867482,"median":-1.976503,"eighty":-0.84984,"marketCap":55536300},{"date":"2024-05-03","current":1.003088,"twenty":-2.855419,"median":-1.966732,"eighty":-0.810293,"marketCap":67248036},{"date":"2024-05-10","current":0.700952,"twenty":-2.849141,"median":-1.962718,"eighty":-0.774953,"marketCap":71026016},{"date":"2024-05-17","current":0.89856,"twenty":-2.849141,"median":-1.954211,"eighty":-0.765697,"marketCap":91049308},{"date":"2024-05-24","current":0.835176,"twenty":-2.849141,"median":-1.949462,"eighty":-0.751393,"marketCap":84626743},{"date":"2024-05-31","current":0.876189,"twenty":-2.849141,"median":-1.938177,"eighty":-0.732881,"marketCap":88782520},{"date":"2024-06-07","current":0.853819,"twenty":-2.849141,"median":-1.926115,"eighty":-0.727833,"marketCap":86515732},{"date":"2024-06-14","current":0.794163,"twenty":-2.849141,"median":-1.92281,"eighty":-0.715212,"marketCap":80470965},{"date":"2024-06-21","current":0.700952,"twenty":-2.849148,"median":-1.912893,"eighty":-0.710164,"marketCap":71026016},{"date":"2024-06-28","current":0.756879,"twenty":-2.849167,"median":-1.907839,"eighty":-0.703432,"marketCap":76692985},{"date":"2024-07-05","current":0.723322,"twenty":-2.849167,"median":-1.898161,"eighty":-0.689969,"marketCap":73292804},{"date":"2024-07-12","current":0.827719,"twenty":-2.849167,"median":-1.88847,"eighty":-0.668933,"marketCap":83871147},{"date":"2024-07-15","current":0.820262,"twenty":-2.849167,"median":-1.887585,"eighty":-0.665567,"marketCap":83115551},{"date":"2024-08-02","current":0.760607,"twenty":-2.85698,"median":-1.871593,"eighty":-0.657574,"marketCap":77070783},{"date":"2024-08-09","current":-2.043115,"twenty":-2.85698,"median":-1.868342,"eighty":-0.652105,"marketCap":72305844},{"date":"2024-08-16","current":-1.85057,"twenty":-2.85698,"median":-1.866147,"eighty":-0.652105,"marketCap":65491680},{"date":"2024-08-23","current":-1.797086,"twenty":-2.85698,"median":-1.859416,"eighty":-0.652105,"marketCap":63598857},{"date":"2024-08-30","current":-1.561753,"twenty":-2.85698,"median":-1.85057,"eighty":-0.652105,"marketCap":55270435},{"date":"2024-09-06","current":-1.43339,"twenty":-2.85698,"median":-1.849885,"eighty":-0.652105,"marketCap":50727660},{"date":"2024-09-13","current":-1.43339,"twenty":-2.85698,"median":-1.84055,"eighty":-0.652105,"marketCap":50727660},{"date":"2024-09-20","current":-1.743601,"twenty":-2.85698,"median":-1.82622,"eighty":-0.652105,"marketCap":61706034},{"date":"2024-09-27","current":-1.615238,"twenty":-2.85698,"median":-1.819059,"eighty":-0.652105,"marketCap":57163259},{"date":"2024-10-04","current":-1.508268,"twenty":-2.85698,"median":-1.813763,"eighty":-0.652105,"marketCap":53377612},{"date":"2024-10-11","current":-1.625935,"twenty":-2.85698,"median":-1.809485,"eighty":-0.652105,"marketCap":57541823},{"date":"2024-10-18","current":-1.615238,"twenty":-2.85698,"median":-1.802935,"eighty":-0.652105,"marketCap":57163259},{"date":"2024-10-25","current":-1.551056,"twenty":-2.85698,"median":-1.798004,"eighty":-0.652105,"marketCap":54891871},{"date":"2024-10-31","current":-1.444087,"twenty":-2.85698,"median":-1.779714,"eighty":-0.652105,"marketCap":51106225},{"date":"2024-11-08","current":-1.384828,"twenty":-2.85698,"median":-1.772256,"eighty":-0.652105,"marketCap":50464510},{"date":"2024-11-15","current":-1.311942,"twenty":-2.85698,"median":-1.753854,"eighty":-0.652105,"marketCap":47808483},{"date":"2024-11-22","current":-1.239244,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":45159299},{"date":"2024-11-29","current":-1.426693,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":51990117},{"date":"2024-12-06","current":-1.244451,"twenty":-2.85698,"median":-1.750858,"eighty":-0.652105,"marketCap":45349044},{"date":"2024-12-13","current":-1.155934,"twenty":-2.85698,"median":-1.745046,"eighty":-0.652105,"marketCap":42123380},{"date":"2024-12-20","current":-1.051796,"twenty":-2.85698,"median":-1.738511,"eighty":-0.652105,"marketCap":38328480},{"date":"2024-12-27","current":-1.062209,"twenty":-2.85698,"median":-1.7384,"eighty":-0.652105,"marketCap":38707970},{"date":"2025-01-03","current":-1.510003,"twenty":-2.85698,"median":-1.723834,"eighty":-0.652105,"marketCap":55026036},{"date":"2025-01-10","current":-1.280899,"twenty":-2.85698,"median":-1.715,"eighty":-0.652105,"marketCap":46677258},{"date":"2025-01-17","current":-1.187175,"twenty":-2.85698,"median":-1.711585,"eighty":-0.652105,"marketCap":43261849},{"date":"2025-01-24","current":-1.124692,"twenty":-2.85698,"median":-1.702881,"eighty":-0.652105,"marketCap":40984910},{"date":"2025-01-31","current":-1.14552,"twenty":-2.85698,"median":-1.688654,"eighty":-0.652105,"marketCap":41743890},{"date":"2025-02-07","current":-1.208003,"twenty":-2.85698,"median":-1.678759,"eighty":-0.652105,"marketCap":44020829},{"date":"2025-02-14","current":-1.218417,"twenty":-2.85698,"median":-1.670993,"eighty":-0.652105,"marketCap":44400319},{"date":"2025-02-21","current":-1.150727,"twenty":-2.849174,"median":-1.665968,"eighty":-0.652105,"marketCap":41933635},{"date":"2025-02-28","current":-1.037216,"twenty":-2.849167,"median":-1.651249,"eighty":-0.652105,"marketCap":37797195},{"date":"2025-03-07","current":-0.999726,"twenty":-2.849174,"median":-1.641351,"eighty":-0.652105,"marketCap":36431031},{"date":"2025-03-14","current":-1.530046,"twenty":-2.849174,"median":-1.637825,"eighty":-0.652105,"marketCap":32571618},{"date":"2025-03-21","current":-1.904374,"twenty":-2.849174,"median":-1.647328,"eighty":-0.652105,"marketCap":40540306},{"date":"2025-03-28","current":-1.84944,"twenty":-2.849174,"median":-1.661427,"eighty":-0.652105,"marketCap":39370874},{"date":"2025-04-04","current":-1.649114,"twenty":-2.849174,"median":-1.665968,"eighty":-0.652105,"marketCap":35106346},{"date":"2025-04-11","current":-1.604435,"twenty":-2.849167,"median":-1.665968,"eighty":-0.652105,"marketCap":34155208},{"date":"2025-04-17","current":-1.671088,"twenty":-2.849167,"median":-1.66551,"eighty":-0.652105,"marketCap":35574119},{"date":"2025-04-25","current":-1.950152,"twenty":-2.849174,"median":-1.668722,"eighty":-0.652105,"marketCap":41514833},{"date":"2025-05-02","current":-1.798351,"twenty":-2.849174,"median":-1.670213,"eighty":-0.652105,"marketCap":38283302},{"date":"2025-05-09","current":-1.752939,"twenty":-2.849174,"median":-1.67768,"eighty":-0.652105,"marketCap":37316572},{"date":"2025-05-16","current":-1.792309,"twenty":-2.849174,"median":-1.67768,"eighty":-0.652105,"marketCap":38154665},{"date":"2025-05-23","current":-1.107845,"twenty":-2.849174,"median":-1.668722,"eighty":-0.652105,"marketCap":30011521},{"date":"2025-05-30","current":-1.28685,"twenty":-2.849174,"median":-1.662372,"eighty":-0.652105,"marketCap":34860765},{"date":"2025-06-06","current":-1.275757,"twenty":-2.849174,"median":-1.649114,"eighty":-0.652105,"marketCap":34560256},{"date":"2025-06-13","current":-1.184004,"twenty":-2.849174,"median":-1.637825,"eighty":-0.652105,"marketCap":32074665},{"date":"2025-06-20","current":-1.072373,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":29050593},{"date":"2025-06-27","current":-1.06085,"twenty":-2.849174,"median":-1.627717,"eighty":-0.651264,"marketCap":28738431},{"date":"2025-07-03","current":-1.053504,"twenty":-2.849174,"median":-1.623082,"eighty":-0.651264,"marketCap":28539428},{"date":"2025-07-11","current":-1.008276,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":27314191},{"date":"2025-07-18","current":-1.065892,"twenty":-2.849174,"median":-1.598124,"eighty":-0.651264,"marketCap":28875002},{"date":"2025-07-25","current":-1.063011,"twenty":-2.849174,"median":-1.593463,"eighty":-0.651264,"marketCap":28796962},{"date":"2025-08-01","current":-0.994016,"twenty":-2.849174,"median":-1.584592,"eighty":-0.651264,"marketCap":26927891},{"date":"2025-08-08","current":-1.260345,"twenty":-2.849174,"median":-1.580614,"eighty":-0.651264,"marketCap":34142739},{"date":"2025-08-15","current":-1.721936,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":33607032},{"date":"2025-08-22","current":-1.749218,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":34139479},{"date":"2025-08-29","current":-1.825476,"twenty":-2.849174,"median":-1.57245,"eighty":-0.651264,"marketCap":35627814},{"date":"2025-09-05","current":-1.866505,"twenty":-2.849174,"median":-1.576968,"eighty":-0.650422,"marketCap":36428581},{"date":"2025-09-12","current":-2.534787,"twenty":-2.849174,"median":-1.583636,"eighty":-0.651264,"marketCap":49471430},{"date":"2025-09-19","current":-2.341455,"twenty":-2.849174,"median":-1.593463,"eighty":-0.651264,"marketCap":45698185},{"date":"2025-09-26","current":-2.319974,"twenty":-2.849174,"median":-1.598124,"eighty":-0.651264,"marketCap":45278936},{"date":"2025-10-03","current":-1.710551,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":33384830},{"date":"2025-10-10","current":-1.700455,"twenty":-2.849174,"median":-1.615238,"eighty":-0.651264,"marketCap":33187783},{"date":"2025-10-17","current":-1.718499,"twenty":-2.849174,"median":-1.628524,"eighty":-0.651264,"marketCap":33539952},{"date":"2025-10-24","current":-1.654056,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":32282204},{"date":"2025-10-31","current":-1.475761,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":28802434},{"date":"2025-11-07","current":-0.988302,"twenty":-2.849174,"median":-1.636631,"eighty":-0.651264,"marketCap":25004034},{"date":"2025-11-14","current":-0.978798,"twenty":-2.849174,"median":-1.625935,"eighty":-0.651264,"marketCap":24763580},{"date":"2025-11-21","current":-1.144502,"twenty":-2.849174,"median":-1.616388,"eighty":-0.651264,"marketCap":28955890},{"date":"2025-11-28","current":-1.144667,"twenty":-2.849174,"median":-1.613106,"eighty":-0.651264,"marketCap":28960086},{"date":"2025-12-05","current":-1.109669,"twenty":-2.849174,"median":-1.598072,"eighty":-0.651264,"marketCap":28074623},{"date":"2025-12-12","current":-1.069528,"twenty":-2.83878,"median":-1.592386,"eighty":-0.651264,"marketCap":27059069},{"date":"2025-12-19","current":-1.045809,"twenty":-2.827318,"median":-1.583147,"eighty":-0.651264,"marketCap":26458969},{"date":"2025-12-26","current":-0.987091,"twenty":-2.819962,"median":-1.57245,"eighty":-0.651264,"marketCap":24973406},{"date":"2026-01-02","current":-1.048961,"twenty":-2.809035,"median":-1.570701,"eighty":-0.651264,"marketCap":26538702},{"date":"2026-01-09","current":-1.104029,"twenty":-2.790757,"median":-1.561753,"eighty":-0.651264,"marketCap":27931942},{"date":"2026-01-16","current":-1.06505,"twenty":-2.777078,"median":-1.539254,"eighty":-0.651264,"marketCap":26945763},{"date":"2026-01-23","current":-1.25381,"twenty":-2.766957,"median":-1.529662,"eighty":-0.651264,"marketCap":31721387},{"date":"2026-01-30","current":-1.228266,"twenty":-2.752248,"median":-1.507534,"eighty":-0.651264,"marketCap":31075125},{"date":"2026-02-06","current":-1.145165,"twenty":-2.740507,"median":-1.497218,"eighty":-0.651264,"marketCap":28972676}],"updateTime":1770572487608},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCYX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606671906","title":"SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671906","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671906?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605200,"startTime":"0","endTime":"0","summary":"This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan.  28, 2026  (G","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227560/0/en/SCYNEXIS-Announces-Presentations-Highlighting-the-Potent-Antifungal-Activity-of-its-Second-Generation-Fungerp-SCY-247-Against-Drug-Resistant-Fungi-at-the-Inaugural-Interdisciplinar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASM","IDSA","SCY","SCYX","VVC","BK4007","BK4188"],"gpt_icon":0},{"id":"2605410229","title":"BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247","url":"https://stock-news.laohu8.com/highlight/detail?id=2605410229","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605410229?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:01","pubTimestamp":1769000519,"startTime":"0","endTime":"0","summary":"BRIEF-SCYNEXIS Receives FDA Qualified Infectious Disease Product And Fast Track Designations For SCY-247Jan 21 (Reuters) - SCYNEXIS Inc SCYX.O:SCYNEXIS RECEIVES FDA QUALIFIED INFECTIOUS DISEASE PRODUC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA45C3JQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2605102460","title":"Scynexis Inc - to Initiate Phase 1 and 2 Studies of Scy-247 in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102460?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA45C3JQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2605102448","title":"Scynexis Inc - Qidp Designation Ensures 10 Years Market Exclusivity for Scy-247","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102448?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA45C3JQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2593803480","title":"SCYNEXIS Granted Nasdaq Extension to Regain Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2593803480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593803480?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:03","pubTimestamp":1766408610,"startTime":"0","endTime":"0","summary":"SCYNEXIS Inc. is currently addressing a regulatory compliance issue related to the Nasdaq minimum bid price requirement. The company has been granted a 180-day extension by Nasdaq to raise its share price to at least $1.00 per share for a minimum of ten consecutive business days. Failure to meet this requirement could impact SCYNEXIS’s continued listing on the Nasdaq Capital Market. The company has stated its intention to take all necessary actions, including a potential reverse stock split, to regain compliance within the extension period. No other regulatory issues or tariffs are mentioned as impacting the company at this time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SCYNEXIS Inc. published the original content used to generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL6TfvkW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SCYX","BK4007","SG9999014005.SGD","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2593487038","title":"Scynexis Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487038?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:00","pubTimestamp":1766408403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUATRLJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2584941460","title":"Scynexis Transfers Brexafemme New Drug Application to GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941460","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941460?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:24","pubTimestamp":1763558663,"startTime":"0","endTime":"0","summary":"Scynexis  said Wednesday it has completed the transfer of the new drug application for Brexafemme, or ibrexafungerp, to GSK .The transfer allows GSK to begin working with the US Food and Drug Administration on a plan to relaunch Brexafemme for vulvovaginal candidiasis and refractory vulvovaginal candidiasis in the US, Scynexis Chief Executive Officer David Angulo said.Following a relaunch, Scynexis said it could receive up to $145.5 million in annual net sales milestones as well as low to mid-single-digit royalties on net sales.Shares of Scynexis were up over 5% in recent Wednesday premarket activity, while GSK was down 0.5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK","LU1829250122.USD","SCYX","BK4007","BK4532","BK4588","BK4585","GSK.UK"],"gpt_icon":0},{"id":"2584945905","title":"Scynexis Inc - to Receive up to $145.5 Mln in Annual Net Sales Milestones as Well as Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945905","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584945905?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA6D3V6W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2584094567","title":"Scynexis Completes Transfer of Brexafemme® New Drug Application to GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2584094567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584094567?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA6D3V6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2584161945","title":"SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2584161945","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584161945?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553600,"startTime":"0","endTime":"0","summary":"GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190785/0/en/SCYNEXIS-Completes-Transfer-of-BREXAFEMME-New-Drug-Application-to-GSK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1829250122.USD","BK4007","BK4532","VVC","GSK.UK","SCYX","BK4585","GSK"],"gpt_icon":0},{"id":"2584627587","title":"Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2584627587","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584627587?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:20","pubTimestamp":1763392808,"startTime":"0","endTime":"0","summary":"SCYNEXIS (SCYX) announced that a novel series of antifungal compounds utilizing SCYNEXIS’ proprietary triterpenoid antifungal platform are among th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scynexis-announces-grant-for-hackensack-meridian-johns-hopkins-collaboration-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scynexis-announces-grant-for-hackensack-meridian-johns-hopkins-collaboration-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","EBSB","SCYX"],"gpt_icon":0},{"id":"2584622418","title":"SCYNEXIS and Partners Secure $7 Million Annual NIH Grant for Novel Antifungal Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2584622418","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584622418?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:19","pubTimestamp":1763392751,"startTime":"0","endTime":"0","summary":"SCYNEXIS Inc. announced that a novel series of antifungal compounds from its proprietary triterpenoid antifungal platform will be part of a new federally funded research initiative. The five-year federal grant, totaling approximately $7 million annually, was awarded to a consortium led by researchers from the Hackensack Meridian Center for Discovery and Innovation  and the Johns Hopkins Bloomberg School of Public Health, with SCYNEXIS and other academic and commercial collaborators participating. The funding, provided by the National Institutes of Health's National Institute of Allergy and Infectious Diseases , will support the Center of Excellence in Translational Research  and accelerate the development of new therapeutics for resistant fungal infections, including SCYNEXIS's next-generation fungerp candidates.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL3Mh3b3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2584622145","title":"Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2584622145","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584622145?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:15","pubTimestamp":1763392500,"startTime":"0","endTime":"0","summary":"Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat resistant fungal infections, including the Company’s next gene","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189320/0/en/Scynexis-Announces-Federal-Funding-of-Collaboration-Between-Hackensack-Meridian-CDI-and-Johns-Hopkins-Researchers-to-Develop-New-Therapeutics-Including-Novel-Fungerps-for-Resistant.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VVC","BK4007","AMR","BK4539","SCYX","BK4588","BK4139","BK4006","BK4585","EBSB"],"gpt_icon":0},{"id":"2581014875","title":"SCYNEXIS Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2581014875","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581014875?lang=en_us&edition=fundamental","pubTime":"2025-11-07 03:45","pubTimestamp":1762458305,"startTime":"0","endTime":"0","summary":"SCYNEXIS Inc reports results for the quarter ended September 30 - Earnings SummarySCYNEXIS Inc SCYX.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended September 30, lowe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL8N3WI3IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2581085921","title":"Antifungal drug developer Scynexis's Q3 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2581085921","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581085921?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:53","pubTimestamp":1762383235,"startTime":"0","endTime":"0","summary":"Antifungal drug developer Scynexis's Q3 net loss widensOverviewScynexis Q3 2025 net loss widens to $8.6 mlnCompany receives $24.8 mln one-time payment from GSK, extending cash runway over two yearsOut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL1N3WH1KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2581704030","title":"BRIEF-Scynexis Q3 Pretax Profit USD -8.591 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581704030","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581704030?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:20","pubTimestamp":1762377646,"startTime":"0","endTime":"0","summary":"BRIEF-Scynexis Q3 Pretax Profit USD -8.591 Million\n\n\nNov 05 (Reuters) - Scynexis Q3 product revenue USD 334 thousand.\n\nQ3 operating expenses USD 8.739 million\nQ3 basic EPS USD -0.17\nQ3 net income USD -8.591 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLX068EA6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SCYX"],"gpt_icon":0},{"id":"2581704752","title":"Scynexis Q3 Basic EPS USD -0.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2581704752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581704752?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:20","pubTimestamp":1762377601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLX068EA6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2580438894","title":"SCYNEXIS Inc  expected to post a loss of 20 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580438894","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580438894?lang=en_us&edition=fundamental","pubTime":"2025-11-01 08:36","pubTimestamp":1761957365,"startTime":"0","endTime":"0","summary":"SCYNEXIS Inc  expected to post a loss of20cents a share - Earnings Preview SCYNEXIS Inc SCYX.OQ SCYX.O is expected to  show a fall in quarterly revenue when it reports  results on November 4 (estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251101:nL8N3WD013:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2578954778","title":"Scynexis Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2578954778","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578954778?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:51","pubTimestamp":1761655860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SCYX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 28, 2025 08:51 ET (12:51 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCYX","BK4007"],"gpt_icon":0},{"id":"2575499780","title":"Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2575499780","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575499780?lang=en_us&edition=fundamental","pubTime":"2025-10-15 21:14","pubTimestamp":1760534070,"startTime":"0","endTime":"0","summary":"Scynexis  said Wednesday it will receive a $22 million payment from GSK's   GlaxoSmithKline Intellectual Property  Limited, resolving the disagreement related to the restart of the phase 3 Mario study on invasive candidiasis.As per resolution terms, Scynexis will terminate the Mario study and receive an additional $2.3 million payment, the company said, adding that Scynexis will not get any milestone related payments from GSK associated with the study.GSK has reiterated its committed to continue its collaboration with the company for the commercialization of Brexafemme, or ibrexafungerp tablets, for vulvovaginal and refractory vulvovaginal candidiasis indications, Scynexis said.Scynexis said GSK's payments, along with its cash in and removal of Mario study expenditures, are expected to extend its cash runway to more than two years.Shares of the company were up over 13% in recent Wednesday trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SCYX","GSK","LU1829250122.USD","BK4588","BK4585","BK4532","GSK.UK"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}